Hossain, M.Z.; Ando, H.; Unno, S.; Kitagawa, J.
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. Int. J. Mol. Sci. 2020, 21, 1423.
https://doi.org/10.3390/ijms21041423
AMA Style
Hossain MZ, Ando H, Unno S, Kitagawa J.
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. International Journal of Molecular Sciences. 2020; 21(4):1423.
https://doi.org/10.3390/ijms21041423
Chicago/Turabian Style
Hossain, Mohammad Zakir, Hiroshi Ando, Shumpei Unno, and Junichi Kitagawa.
2020. "Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain" International Journal of Molecular Sciences 21, no. 4: 1423.
https://doi.org/10.3390/ijms21041423
APA Style
Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J.
(2020). Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. International Journal of Molecular Sciences, 21(4), 1423.
https://doi.org/10.3390/ijms21041423